中文簡(jiǎn)介

《免疫學(xué)快報(bào)》提供了一種快速出版長(zhǎng)篇和短篇文章、快速筆記、(迷你)評(píng)論和給編輯的信件的工具，這些信件涉及分子和細(xì)胞免疫學(xué)的所有方面。出版的基本標(biāo)準(zhǔn)將是清晰、實(shí)驗(yàn)的健全和新穎。與當(dāng)前公認(rèn)的想法相矛盾的結(jié)果或與實(shí)際教條相背離的想法，只要它們是基于堅(jiān)實(shí)的實(shí)驗(yàn)結(jié)果，將被考慮發(fā)表。優(yōu)先考慮對(duì)其他研究者具有直接重要性的論文，無(wú)論是通過(guò)他們的實(shí)驗(yàn)數(shù)據(jù)、新觀(guān)點(diǎn)還是新方法。與已發(fā)表論文有關(guān)的科學(xué)函電也可接受，但必須簡(jiǎn)短，并與所述論文有科學(xué)上的聯(lián)系，以便提供一個(gè)繼續(xù)討論的論壇。在參考區(qū)，考慮發(fā)表功能未知的新mRNA序列、具有組織分布的表達(dá)序列標(biāo)記和新的單克隆抗體描述。

投稿網(wǎng)址：http://ees.elsevier.com/imlet/default.asp?acw=8

英文簡(jiǎn)介

Immunology Letters provides a vehicle for the speedy publication of full-length and short articles, Rapid Notes, (mini)Reviews and Letters to the Editor addressing all aspects of molecular and cellular immunology. The essential criteria for publication will be clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas will be considered for publication provided that they are based on solid experimental findings. Preference will be given to papers of immediate importance to other investigators, either by their experimental data, new ideas or new methodology. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided that they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion. Within a reference section, new mRNA sequences with unknown function, expressed sequence tags with tissue distribution and novel monoclonal antibody descriptions are considered for publication.